Filter News
Area of Research
- (-) Isotopes (5)
- (-) National Security (2)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Materials (7)
- Materials for Computing (2)
- Neutron Science (11)
- Supercomputing (17)
News Topics
- (-) Biomedical (9)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (12)
- Artificial Intelligence (12)
- Big Data (6)
- Bioenergy (4)
- Biology (5)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (6)
- Computer Science (22)
- Coronavirus (3)
- Cybersecurity (19)
- Decarbonization (3)
- Energy Storage (3)
- Environment (7)
- Exascale Computing (1)
- Frontier (1)
- Fusion (9)
- Grid (6)
- High-Performance Computing (4)
- Irradiation (1)
- Isotopes (29)
- Machine Learning (12)
- Materials (6)
- Materials Science (8)
- Molten Salt (4)
- Nanotechnology (1)
- National Security (35)
- Neutron Science (9)
- Nuclear Energy (43)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Security (12)
- Simulation (1)
- Space Exploration (9)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.